Virion Therapeutics
Virion Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.
About Virion Therapeutics
Virion Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Virion Therapeutics is a clinical-stage biopharmaceutical company developing proprietary T cell-based immunotherapies that enhance CD8+ T cell responses to treat cancer and chronic infectious diseases, with a lead program VRON-0200 targeting chronic hepatitis B virus that completed Phase 1b trials.
Explore Virion Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.